Press Releases

Press Releases

All Releases
Aug 15, 2013
Ophthotech Corporation Files Registration Statement for Proposed Initial Public Offering New York, NY—August 15, 2013 – Ophthotech Corporation today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”)
Jan 03, 2013
Ophthotech to Present at 31st Annual J.P. Morgan Healthcare Conference Princeton, NJ and New York, NY – January 3, 2013 – Ophthotech Corp. announced today that the company will participate in the 31st Annual J.P. Morgan Healthcare Conference to be held Jan. 7-10, 2013.
Oct 24, 2012
Positive Results from Phase 2b Study of Ophthotech’s Novel Anti-PDGF Combination Agent Fovista™ to be Presented at AAO Retina Subspecialty Day Princeton, NJ – October 24, 2012 – Ophthotech Corporation today announced that data from a large, prospective, randomized,
Jan 03, 2012
Ophthotech to Present at 30th Annual J.P. Morgan Healthcare Conference Princeton, NJ and New York, NY – January 3, 2012 – Ophthotech Corp. announced today that the company will participate in the 30th Annual J.P. Morgan Healthcare Conference in San Francisco.